Distribution of bacterial pathogens and antimicrobial resistance in cows with clinical mastitis in a dairy farm, Turkiye

Abstract

This study aimed to identify the pathogens causing clinical mastitis (CM)and their resistance levels to six common antimicrobials in a dairy farm in T & uuml;rkiye. A total of 973 CM milk samples were cultured and a Kirby-Bauer disc diffusion method was performed for antimicrobial susceptibility. While 64.0% (623/973) of CM samples were culture-positive, 36.0% (350/973) of CM samples yielded no growth. Escherichia coli was the most frequently isolated pathogen (36.3%), followed by coagulase-negative staphylococci (8.3%), Streptococcusdysgalactiae (7.3%), Staphylococcus aureus (3.1%), Streptococcus uberis (1.5%), Enterococcusspp. (1.4%), Mycoplasma spp. (1.4%), Streptococcus agalactiae (0.7%), and Corynebacterium spp. (0.4%). Antimicrobial resistance was higher (P >0.01) to amoxicillin/clavulanic acid (AMC, 32.3%) than that to enrofloxacin (ENR, 23.4%), cefoperazone (CFP, 17.9%), cefquinome (CEQ, 17.7%), penicillin G (P, 15.2%), and gentamicin (CN, 3.6%) in culture-positive 642 isolates. For E. coli isolates, percentage of resistance to AMC, ENR, CFP, CEQ, P, and CN was 37.7, 30.6, 24.4, 23.2, 5.9, and 1.1%, respectively. Resistance to AMC (31.2%) and P (46.3%) was higher in CNS than Strep. dysgalactiae isolates (1.5% and 12.7%), respectively. Multidrug resistance was detected in 34 E. coli isolates (9.6%), 7 CNS isolates (8.6%), and 2 Strep. dysgalactiae (2.8%). In conclusion, the higher identification of E. coli demonstrated the higher risk of environmental microorganisms for CM in this study. Higher resistance to commonly used five of six antimicrobials showed the requirement of frequent bacteriological and antimicrobial susceptibility tests for CM. Thus, proper hygienic programs may help to reduce the clinical mastitis caused by environmental pathogens in high-yielding cows. The determination of mastitis pathogens and antimicrobial resistance in cows may help to improve the treatment efficacy and welfare of dairy cows with clinical mastitis as well as the production of safe milk for consumers.